14.2 Obesity, Weight Management & Healthy Lifestyle Counseling
Key Takeaways
Obesity is a BMI of 30 or higher (27.5 or higher in Asian adults), and a waist circumference over 35 inches signals central adiposity in women.
The USPSTF recommends offering or referring adults with a BMI of 30 or higher to intensive, multicomponent behavioral interventions (grade B).
Adults need 150–300 minutes of moderate (or 75–150 minutes of vigorous) aerobic activity weekly plus muscle strengthening on at least 2 days (Physical Activity Guidelines, 2nd edition).
Anti-obesity medications are contraindicated in pregnancy; semaglutide is stopped at least 2 months before conception, and phentermine-topiramate requires a REMS because topiramate causes oral clefts.
Tirzepatide can reduce oral contraceptive absorption, so patients should switch to a non-oral method or add a barrier method for 4 weeks after starting and after each dose increase.
Assessment
| Category | BMI (kg/m²) | Asian-Ancestry Cutoffs |
|---|---|---|
| Overweight | 25.0–29.9 | 23.0–27.4 |
| Obesity class I | 30.0–34.9 | 27.5 or higher |
| Obesity class II | 35.0–39.9 | |
| Obesity class III | 40 or higher |
BMI misclassifies some patients, so add waist circumference (over 35 inches / 88 cm in women) and assess weight-related conditions: type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, metabolic dysfunction–associated steatotic liver disease (MASLD), PCOS, infertility, osteoarthritis, GERD, urinary incontinence, depression, and several cancers (endometrial, postmenopausal breast, colorectal).
Review weight-promoting drugs: antipsychotics, mirtazapine, some SSRIs (paroxetine), insulin and sulfonylureas, glucocorticoids, gabapentinoids, and DMPA (which can add weight in some users). Screen for binge-eating disorder before prescribing; lisdexamfetamine is approved for binge-eating disorder.
Use person-first, nonstigmatizing language ("a patient with obesity"), and ask permission before discussing weight.
Behavioral Counseling
- USPSTF (grade B): Offer or refer adults with a BMI of 30 or higher to intensive, multicomponent behavioral interventions (typically 12 or more sessions in the first year) combining diet, physical activity, self-monitoring, and goal setting. A 5%–10% weight loss improves blood pressure, glucose, lipids, and ovulation in PCOS.
- The USPSTF also recommends behavioral counseling on healthy diet and activity for adults with cardiovascular risk factors.
Diet (Dietary Guidelines for Americans, 2025–2030)
Released January 7, 2026, the guidelines emphasize whole, minimally processed foods ("eat real food"): vegetables, fruits, whole grains, adequate protein (about 1.2–1.6 g/kg/day), and dairy, while keeping saturated fat below 10% of calories, sodium below 2,300 mg/day, and added sugars to a minimum. They advise drinking less alcohol without setting a numeric limit. Any sustainable calorie deficit (Mediterranean, DASH, lower-carbohydrate) works; adherence matters more than the specific pattern.
Physical Activity (Physical Activity Guidelines, 2nd Edition)
- 150–300 minutes per week of moderate aerobic activity (or 75–150 minutes vigorous), plus muscle strengthening on 2 or more days.
- Older adults add balance training to prevent falls.
- Pregnancy and postpartum: at least 150 minutes of moderate activity weekly unless contraindicated.
- Weight maintenance after loss often needs more activity, about 200–300 minutes weekly.
Stress, Sleep, and Healthy Habits
Chronic stress and short sleep (under 7 hours) increase appetite hormones and weight gain. Recommend stress-reduction techniques (mindfulness, CBT, social support), consistent sleep, tobacco cessation, and moderation or avoidance of alcohol.
Anti-Obesity Medications
Indicated for a BMI of 30 or higher, or 27 or higher with a weight-related condition, together with lifestyle change.
| Drug | Typical Weight Loss | Key Safety Points |
|---|---|---|
| Semaglutide 2.4 mg weekly (GLP-1 receptor agonist) | About 15% | GI effects, gallbladder disease, pancreatitis; boxed warning for thyroid C-cell tumors (avoid with personal or family history of medullary thyroid cancer or MEN2); stop at least 2 months before planned conception |
| Tirzepatide (GIP/GLP-1 agonist) | About 20% | Same class warnings; reduces oral contraceptive absorption: use a non-oral method or add a barrier method for 4 weeks after starting and after each dose increase |
| Liraglutide 3 mg daily | About 5%–8% | Daily injection |
| Phentermine-topiramate ER | About 8%–10% | REMS: topiramate causes oral clefts, so a negative pregnancy test before starting and reliable contraception are required; avoid with glaucoma or hyperthyroidism |
| Naltrexone-bupropion | About 5% | Boxed warning for suicidal thoughts; lowers seizure threshold; avoid with uncontrolled hypertension or opioid use |
| Orlistat | About 3%–5% | Oily stools; take a fat-soluble vitamin supplement |
GLP-1 drugs slow gastric emptying, which can affect oral drug absorption, and rapid weight loss can restore ovulation in women with PCOS or obesity, producing unplanned pregnancies. Every anti-obesity medication is contraindicated in pregnancy, so contraception counseling is part of prescribing.
Bariatric (Metabolic) Surgery
- Indications (ASMBS/IFSO 2022): BMI of 35 or higher regardless of comorbidity, or 30–34.9 with metabolic disease; lower thresholds apply to Asian patients. Sleeve gastrectomy is the most common procedure, followed by Roux-en-Y gastric bypass.
- Reproductive counseling:
- Fertility often improves quickly, so delay pregnancy 12–18 months after surgery, during rapid weight loss.
- After a malabsorptive procedure (Roux-en-Y), oral contraceptives may be absorbed poorly (US MEC Category 3 for combined and progestin-only pills), so prefer LARC, the patch, the ring, or DMPA.
- Monitor iron, B12, folate, vitamin D, and calcium, and supplement lifelong.
- In pregnancy after gastric bypass, avoid the glucose-load screening test (dumping syndrome) and evaluate abdominal pain promptly for internal hernia.
Counseling Approach: The 5 As
- Ask permission to discuss weight, and avoid stigmatizing language.
- Assess BMI, waist circumference, related conditions, readiness to change, and root causes (sleep, mood, medications, stress, food insecurity).
- Advise on health benefits of modest weight loss and treatment options, including behavioral programs, medications, and surgery.
- Agree on realistic, specific goals (for example, a 5% loss in 6 months or 150 minutes of walking weekly) using motivational interviewing.
- Assist and arrange referrals (dietitian, behavioral program, obesity medicine, bariatric surgery) and follow-up.
Weight bias in health care leads patients to delay care and avoid screening, so a respectful, chronic-disease approach improves outcomes.
A 32-year-old with obesity (BMI 36) and PCOS starts tirzepatide for weight management. She uses a combined oral contraceptive and does not want pregnancy. What counseling is most important?
Tirzepatide increases oral contraceptive levels, so she should switch to a lower-dose pill.
No contraception is needed, because tirzepatide reliably suppresses ovulation in PCOS.
She should stop contraception because weight loss lowers VTE risk enough to make it unnecessary.
Use a non-oral method, or add a barrier method for 4 weeks after starting and each dose increase.
A 45-year-old woman with a BMI of 31 asks how much exercise she needs for health. According to the Physical Activity Guidelines for Americans (2nd edition), what is the recommendation for adults?
150–300 minutes of moderate aerobic activity weekly plus muscle strengthening on 2 or more days
30 minutes of brisk walking once weekly plus stretching on 2 or more days
10,000 steps every day, which replaces any need for aerobic minutes or strength training
60 minutes of vigorous exercise daily, 7 days a week, plus daily resistance training
A 28-year-old is considering phentermine-topiramate ER for obesity. She is sexually active and uses condoms inconsistently. Which statement about this medication is correct?
It is safe in pregnancy and may simply be continued at the same dose if she conceives.
Topiramate can cause oral clefts, so it requires a negative pregnancy test and reliable contraception.
It requires monthly liver function tests and a liver biopsy after the first year.
It works mainly by blocking dietary fat absorption, so a fat-soluble vitamin supplement is required.
Sections you finish are checked off in the contents.